Bacterial Infections and Antimicrobial Resistance
Bacterial Infections and Antimicrobial Resistance
Antimicrobial resistance (AMR) is a global problem and we are innovating to solve one this biggest growing threat to global healthcare. Surgical Site Infections (SSIs) and Hospital Acquired Infections (HAIs) remain an ongoing and dangerous global health crisis in the United States and worldwide. Worldwide more than 3 million people die annually from HAIs. The problem is only getting worse. Because of the pervasive use of antibiotics, bacteria have responded by evolving to be ever more resistant to treatment. It is predicted that by 2050, upwards of 10 million people globally will
be killed each year by so-called “superbugs.”
Sonix-A8 is a revolutionary technology that provides an antibiotic-free solution to fight bacterial infections and combat AMR.
2019 Antibiotic Resistance Threats Report
CDC’s Antibiotic Resistance Threats in the United States, 2019 (2019 AR Threats Report) includes the latest national death and infection estimates that underscore the continued threat of antibiotic resistance in the U.S.
According to the report, more than 2.8 million antibiotic-resistant infections occur in the U.S. each year, and more than 35,000 people die as a result. In addition, 223,900 cases of Clostridioides difficile occurred in 2017 and at least 12,800 people died.
Dedicated prevention and infection control efforts in the U.S. are working to reduce the number of infections and deaths caused by antibiotic- resistant germs, but the number of people facing antibiotic resistance is still too high. More action is needed to fully protect people.
CDC is concerned about rising resistant infections in the community, which can put more people at risk, make spread more difficult to identify and contain, and threaten the progress made to protect patients in healthcare. The emergence and spread of new forms of resistance remains a concern.
https://www.cdc.gov/drugresistance/pdf/threats-report/Threat-Modern-Medicine-508.pdf
Burden of SSI’s and HAI’s
High Rate
Morbidity & Mortality
75%
Post Operative Deaths
>300%
Increased Hospitalization Cost
2x
Increase in Rehospitalization
Burden of SSI’s and HAI’s
250,000 U.S. deaths from bacterial infections/sepsis each year
Median increase in hospital stays of 14 days, which cost the hospitals $16,000 (non-reimbursable)
Antimicrobial Resistance (AMR) is REAL & will soon become a GLOBAL CRISIS if not addressed
SONIX-A8
Combating Bacterial Infections
Without Antibiotics
Sonix-A8 is innovative technology to prevent and control ALL bacterial infections and combat Antimicrobial Resistance.
